Patents by Inventor Thierry Leveillard

Thierry Leveillard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Rod-derived cone viability factor (RDCVF) and a method of enhancing cone cell survival by RDCVF
    Patent number: 7795387
    Abstract: Disclosed are methods and compositions for early diagnosis, monitoring and treatment of retinal dystrophy, age-related macular degeneration, Bardet-Biedel syndrome, Bassen-kornzweig syndrome, best disease, chroidema, gyrate atrophy, congenital amourosis, refsun syndrome, stargardt disease and Usher syndrome. In particular, the invention relates to a protein, termed 2Rdcvf1,” that is differentially transcribed and expressed in subjects suffering from retinal dystrophies and the like, such as retinal dystrophy and age-related macular degeneration compared with non-sufferers, antibodies which recongnize this protein, and methods for diagnosing such conditions.
    Type: Grant
    Filed: April 5, 2002
    Date of Patent: September 14, 2010
    Assignees: Novartis AG, Universite de Strasbourg
    Inventors: Thierry Léveillard, José Alain Sahel, Saddek Mohand-Said, David Hicks
  • Disease-Associated Protein
    Publication number: 20090062188
    Abstract: Disclosed are methods and compositions for early diagnosis, monitoring and treatment of retinal dystrophy, age-related macular degeneration, Bardet-Biedel syndrome, Bassen-kornzweig syndrome, best disease, choroidema, gyrate atrophy, congenital amourosis, refsun syndrome, stargardt disease and Usher syndrome. In particular, the invention relates to a protein, termed “Rdcvf1,” that is differentially transcribed and expressed in subjects suffering from retinal dystrophies and the like, such as retinal dystrophy and age-related macular degeneration compared with non-sufferers, antibodies which recognize this protein, and methods for diagnosing such conditions.
    Type: Application
    Filed: April 25, 2007
    Publication date: March 5, 2009
    Inventors: Thierry Leveillard, Jose Alain Sahel, Saddek Mohand-Said, David Hicks
  • Disease-Associated Protein
    Publication number: 20080004231
    Abstract: Disclosed are methods and compositions for early diagnosis, monitoring and treatment of retinal dystrophy, age-related macular degeneration, Bardet-Biedel syndrome, Bassen-kornzweig syndrome, best disease, choroidema, gyrate atrophy, congenital amourosis, refsun syndrome, stargardt disease and Usher syndrome. In particular, the invention relates to a protein, termed “Rdcvf1,” that is differentially transcribed and expressed in subjects suffering from retinal dystrophies and the like, such as retinal dystrophy and age-related macular degeneration compared with non-sufferers, antibodies which recognize this protein, and methods for diagnosing such conditions.
    Type: Application
    Filed: April 25, 2007
    Publication date: January 3, 2008
    Inventors: Thierry Leveillard, Jose Sahel, Saddek Mohand-Said, David Hicks
  • Disease- associated protein
    Publication number: 20040204350
    Abstract: Disclosed are methods and compositions for early diagnosis, monitoring and treatment of retinal dystrophy, age-related macular degeneration, Bardet-Biedel syndrome, Bassen-kornzweig syndrome, best disease, chroidema, gyrate atrophy, congenital amourosis, refsun syndrome, stargardt disease and Usher syndrome. In particular, the invention relates to a protein, termed 2Rdcvf1,” that is differentially transcribed and expressed in subjects suffering from retinal dystrophies and the like, such as retinal dystrophy and age-related macular degeneration compared with non-sufferers, antibodies which recongnize this protein, and methods for diagnosing such conditions.
    Type: Application
    Filed: April 2, 2004
    Publication date: October 14, 2004
    Inventors: Thierry Leveillard, Jose Alain Sahel, Saddek Mohand-Said, David Hicks